Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$182,073
-$21,826 QoQ
Shares Held
292
+50.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#498
of 676 holders
Holding Since
Jun 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $1,902,676 across 11 Biotechnology names. REGN ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
223,076 | $876,689 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
916 | $455,004 | |
| 3 | ABCL |
AbCellera Biologics Inc.
|
26,183 | $205,536 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
292 | $182,073 | |
| 5 | DTIL |
Precision Biosciences Inc
|
10,164 | $79,889 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
11,786 | $28,286 | |
| 7 | NMRA |
Neumora Therapeutics, Inc.
|
16,232 | $27,594 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
12,344 | $21,725 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $182,073 | 292 | Shares | Sole | 2026-08-06 | |
| 2024-06-30 | $203,899 | 194 | Shares | Sole | 2024-08-08 | |
| 2020-12-31 | $386,971 | 801 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $523,954 | 936 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $709,713 | 1,138 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||